Profile photo Stefan Prekovic

Stefan Prekovic

Assistant Professor

Strategic program(s):

Biography

Born and raised in a quaint Serbian town, I earned my BSc/MSc degrees from the University of Belgrade before relocating to Belgium. There, I joined Frank Claessens' lab, exploring the androgen receptor's role in diverse diseases. Later, as a postdoctoral researcher at the Netherlands Cancer Institute, I worked with Wilbert Zwart on investigating transcription factor action in various cancer types using omics, screening, and computational methodologies.

Strategic program(s):

Contact

Research groups

Chromatin-related factors and cellular plasticity

Research aim

The group focuses on chromatin-related factors and their effects on cellular phenotypes, employing a range of state-of-the-art omics techniques. Our objective is to uncover targetable pathways that can effectively eliminate cancer cells.

Go to group

Recent publications

Mechanisms that clear mutations drive field cancerization in mammary tissue Marta Ciwinska, Hendrik A. Messal, Hristina R. Hristova, Catrin Lutz, Laura Bornes, Theofilos Chalkiadakis, Rolf Harkes, Nathalia S.M. Langedijk, Stefan J. Hutten, Renée X. Menezes, Jos Jonkers, Stefan Prekovic, Marja van Oirsouw, Ellen Verschuur, Donna Pinto, Deborah Collyar, Hilary Stobart, Proteeti Bhattacharjee, Daniel Rea, Lodewyk F.A. Wessels, Marjanka Schmidt, Esther H. Lips, Fariba Behbod, Jacco van Rheenen, Jos Jonkers, E. Shelley Hwang, Nicholas E. Navin, Andrew Futreal, Helen R. Davies, Elinor J. Sawyer, Serena Nik-Zainal, Alastair M. Thompson, Jelle Wesseling, Benjamin D. Simons, Colinda L.G.J. Scheele,
Nature, 2024, vol. 633, p.198-206
Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer Peter D Haughton, Wisse Haakma, Theofilos Chalkiadakis, Gerben E Breimer, Else Driehuis, Hans Clevers, Stefan Willems, Stefan Prekovic, Patrick W B Derksen
Oncogene, 2024, vol. 43, p.2463-2474
Unraveling the molecular interactions between α7 nicotinic receptor and a RIC3 variant associated with backward speech Aditi Pradhan, Hayley Mounford, Jessica Peixinho, Edward Rea, Emmanouela Epeslidou, Julia S Scott, Joanna Cull, Susan Maxwell, Richard Webster, David Beeson, Yin Yao Dong, Stefan Prekovic, Isabel Bermudez, Dianne F Newbury
Cellular and Molecular Life Sciences, 2024, vol. 81, p.1-13
The 2023 generation Joanna Achinger-Kawecka, Santiago Correa, Jing Hu, Gaopeng Li, Rik G H Lindeboom, Sandra Misale, Teresa Monkkonen, Ajit J Nirmal, Stefan Prekovic, Sanju Sinha, Anna S Trigos, Caroline J Watson
Nature Cancer, 2023, vol. 4, p.1630-1635
Perturbations in 3D genome organization can promote acquired drug resistance Anna G Manjón, Stefano Giustino Manzo, Stefan Prekovic, Leon Potgeter, Tom van Schaik, Ning Qing Liu, Koen Flach, Daniel Peric-Hupkes, Stacey Joosten, Hans Teunissen, Anoek Friskes, Mila Ilic, Dorine Hintzen, Vinícius H Franceschini-Santos, Wilbert Zwart, Elzo de Wit, Bas van Steensel, René H Medema
Cell Reports, 2023, vol. 42
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity Stefan Prekovic, Theofilos Chalkiadakis, Merel Roest, Daniel Roden, Catrin Lutz, Karianne Schuurman, Mark Opdam, Liesbeth Hoekman, Nina Abbott, Tanja Tesselaar, Maliha Wajahat, Amy R Dwyer, Isabel Mayayo-Peralta, Gabriela Gomez, Maarten Altelaar, Roderick Beijersbergen, Balázs Győrffy, Leonie Young, Sabine Linn, Jos Jonkers, Wayne Tilley, Theresa Hickey, Damir Vareslija, Alexander Swarbrick, Wilbert Zwart
Embo Molecular Medicine, 2023, vol. 15